Latest Breaking News On - Metastatic small cell neuroendocrine prostate cancer - Page 1 : comparemela.com

BXCL701 has been granted fast track designation for select patients with metastatic small cell neuroendocrine prostate cancer by the FDA.

Vimal mehtaVincentj oneillProstate cancer working groupProduct developmentBioxcel therapeutics incBioxcel therapeuticsOnkosxcel therapeuticsCancers symposiumMedical officerXcel therapeuticsMetastatic small cell neuroendocrine prostate cancer